Mar 19, 2010 | Digital Pathology, Laboratory News, Laboratory Pathology
Human Microbiome Project is expected to trigger many new molecular diagnostic assays Meet the human microbiome, considered by some medical researchers to be the newest biomedical frontier. A major effort to map the human microbiome is expected to identify a significant number of new biomarkers that will be useful in both clinical pathology diagnostic tests and therapeutic drug development. Known as the Human Microbiome Project, the five-year program is funded with $115 million in grants from...
